Source: Annual Congress 2004 - SARS and other lower respiratory tract infections
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. W. Jones, S. Spencer, I. Duprat-Lomon, P. P. Sagnier, R. Wilson (London, Uxbridge, United Kingdom; Puteaux, France). Value of measuring SGRQ at stable phase of COPD to predict the timing and deterioration associated with next exacerbation: the MOSAIC study. Eur Respir J 2004; 24: Suppl. 48, 1572

Member's Comments

No comment yet.

Related content which might interest you: Short-term recovery in SGRQ following a COPD exacerbation in the MOSAIC study correlates with the preceding deterioration, but is larger Source: Eur Respir J 2004; 24: Suppl. 48, 686s Year: 2004 Early occurrence of any COPD exacerbation predicts further higher risk of moderate/severe exacerbations regardless of recording tool: the FLAME study Source: International Congress 2017 – Management of COPD Year: 2017 Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV1 predict treatment failure during hospitalisation due to COPD exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 525s Year: 2007 Determination of the existence of a correlation between lung function decline and changes in the COPD assessment test Source: International Congress 2014 – Clinical presentations Year: 2014 Baseline symptom scores and future risk of severe exacerbation: The SPARK study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008 The relationship between COPD assessment test (CAT) scores and severity of airflow obstruction in stable COPD patients Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012 COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 COPD exacerbations significantly impact quality of life as measured by SGRQ-C total score: results from the FLAME study Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017 Mometasone/indacaterol/glycopyrronium (MF/IND/GLY) improves lung function and reduces exacerbations in patients with asthma, independent of baseline airflow limitation: Results from IRIDIUM study Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT Source: International Congress 2014 – Markers Year: 2014 Does airflow limitation severity in stable condition severity of COPD influences in patient cardiac autonomic modulation in COPD patients during hospitalization for exacerbation? Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Change in BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 The derivation of a new index of severity for COPD patients, the DOSE index: MRC dyspnea scale, airflow obstruction, smoking status and exacerbations Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation Year: 2007 Scales of assesment in COPD. Correlation with clinical and functional parameters Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 6MWT improvement after pulmonary rehabilitation (PR) is inversely associated with degree of airflow obstruction in COPD patients. A retrospective study Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity Year: 2013 Impact of lung function impairment and exacerbation history on COPD patient-reported utility Source: International Congress 2014 – COPD markers Year: 2014 Factors that predict exacerbation severity and recovery measured with the exacerbations of chronic obstructive pulmonary disease (EXACT) tool Source: Annual Congress 2008 - COPD Year: 2008 The availibility of copd assessment test (CAT) in determination of risk of early hospitalization in chronic obstructive pulmonary disease patients and its correlation with pulmonary function tests, dyspnea measurement scales and St George respiratory questionnaire Source: International Congress 2014 – COPD markers Year: 2014